Carrier M - Search Results

1

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.

Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. Among authors: carrier m. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.

2

The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.

Carrier M, Knoll GA, Kovacs MJ, Moore JC, Fergusson D, Rodger MA. Carrier M, et al. Thromb Res. 2007;120(2):215-20. doi: 10.1016/j.thromres.2006.09.014. Epub 2006 Nov 13. Thromb Res. 2007. PMID: 17098277

3

Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex.

Carrier M, Rodger MA, Fergusson D, Doucette S, Kovacs MJ, Moore J, Kelton JG, Knoll GA. Carrier M, et al. Kidney Int. 2008 Jan;73(2):213-9. doi: 10.1038/sj.ki.5002631. Epub 2007 Oct 17. Kidney Int. 2008. PMID: 17943076 Free article.

4

Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients.

Carrier M, Lee AY, Bates SM, Anderson DR, Wells PS. Carrier M, et al. Thromb Res. 2008;123(1):177-83. doi: 10.1016/j.thromres.2008.05.002. Epub 2008 Jun 16. Thromb Res. 2008. PMID: 18558426

5

Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?

Carrier M, Le Gal G, Wells PS, Fergusson D, Ramsay T, Rodger MA. Carrier M, et al. Ann Intern Med. 2008 Sep 2;149(5):323-33. doi: 10.7326/0003-4819-149-5-200809020-00007. Ann Intern Med. 2008. PMID: 18765702 Review.

6

Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology.

Carrier M, Lee AY. Carrier M, et al. Nat Clin Pract Oncol. 2009 Feb;6(2):74-84. doi: 10.1038/ncponc1244. Epub 2008 Oct 28. Nat Clin Pract Oncol. 2009. PMID: 18957949 Review.

7

Validation of a diagnostic approach to exclude recurrent venous thromboembolism.

Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Perrier A, White RH, Vickars L, Rodger M. Le Gal G, et al. Among authors: carrier m. J Thromb Haemost. 2009 May;7(5):752-9. doi: 10.1111/j.1538-7836.2009.03324.x. Epub 2009 Feb 18. J Thromb Haemost. 2009. PMID: 19228281 Free article.

8

Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.

Carrier M, Le Gal G, Cho R, Tierney S, Rodger M, Lee AY. Carrier M, et al. J Thromb Haemost. 2009 May;7(5):760-5. doi: 10.1111/j.1538-7836.2009.03326.x. Epub 2009 Feb 24. J Thromb Haemost. 2009. PMID: 19245418 Free article.

9

VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies.

Carrier M, Righini M, Djurabi RK, Huisman MV, Perrier A, Wells PS, Rodger M, Wuillemin WA, Le Gal G. Carrier M, et al. Thromb Haemost. 2009 May;101(5):886-92. Thromb Haemost. 2009. PMID: 19404542 Review.

10

Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.

Carrier M, Le Gal G, Wells PS, Rodger MA. Carrier M, et al. Ann Intern Med. 2010 May 4;152(9):578-89. doi: 10.7326/0003-4819-152-9-201005040-00008. Ann Intern Med. 2010. PMID: 20439576 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,143 results

Search Page

Filters